Literature DB >> 1857967

Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.

W A Pieken1, D B Olsen, F Benseler, H Aurup, F Eckstein.   

Abstract

The incorporation of 2'-fluoro- and 2'-aminonucleotides into a hammerhead ribozyme was accomplished by automated chemical synthesis. The presence of 2'-fluorouridines, 2'-fluorocytidines, or 2'-aminouridines did not appreciably decrease catalytic efficiency. Incorporation of 2'-aminocytidines decreased ribozyme activity approximately by a factor of 20. The replacement of all adenosines with 2'-fluoroadenosines abolished catalysis in the presence of MgCl2 within the limits of detection, but some activity was retained in the presence of MnCl2. This effect on catalysis was localized to a specific group of adenines within the conserved single-stranded region of the ribozyme. The decrease in catalytic efficiency was caused by a decrease in the rate constant; the Michaelis constant was unaltered. The 2'-fluoro and 2'-amino modifications conferred resistance toward ribonuclease degradation. Ribozymes containing 2'-fluoro- or 2'-aminonucleotides at all uridine and cytidine positions were stabilized against degradation in rabbit serum by a factor of at least 10(3) compared to unmodified ribozyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857967     DOI: 10.1126/science.1857967

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  126 in total

1.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Developing aptamers into therapeutics.

Authors:  R R White; B A Sullenger; C P Rusconi
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Escort aptamers: a delivery service for diagnosis and therapy.

Authors:  B J Hicke; A W Stephens
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

4.  Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers.

Authors:  Mihaela Lorger; Markus Engstler; Matthias Homann; H Ulrich Göringer
Journal:  Eukaryot Cell       Date:  2003-02

5.  RNaseCut: a MALDI mass spectrometry-based method for SNP discovery.

Authors:  Stefan Krebs; Ivica Medugorac; Doris Seichter; Martin Förster
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

6.  A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability.

Authors:  P Hendry; M J McCall; F S Santiago; P A Jennings
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

7.  Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation.

Authors:  J Goodchild
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

Review 8.  Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

Review 9.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

Review 10.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.